Your browser doesn't support javascript.
loading
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306.
Tanaka, Kazuhiro; Machida, Ryunosuke; Kawai, Akira; Nakayama, Robert; Tsukushi, Satoshi; Asanuma, Kunihiro; Matsumoto, Yoshihiro; Hiraga, Hiroaki; Hiraoka, Koji; Watanuki, Munenori; Yonemoto, Tsukasa; Abe, Satoshi; Katagiri, Hirohisa; Nishida, Yoshihiro; Nagano, Akihito; Suehara, Yoshiyuki; Kawashima, Hiroyuki; Kawano, Masanori; Morii, Takeshi; Hatano, Hiroshi; Toguchida, Junya; Okuma, Tomotake; Takeyama, Masanobu; Takenaka, Satoshi; Akisue, Toshihiro; Furuta, Taisuke; Emori, Makoto; Hiruma, Toru; Outani, Hidetatsu; Yamamoto, Tetsuji; Kataoka, Tomoko; Fukuda, Haruhiko; Ozaki, Toshifumi; Iwamoto, Yukihide.
Afiliação
  • Tanaka K; Department of Orthopaedic Surgery, Oita University, Oita, Japan. ktanaka@oita-u.ac.jp.
  • Machida R; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Kawai A; Division of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Nakayama R; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Tsukushi S; Department of Orthopaedic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Asanuma K; Department of Orthopaedic Surgery, Mie University, Mie, Japan.
  • Matsumoto Y; Department of Orthopaedic Surgery, Kyusyu University, Fukuoka, Japan.
  • Hiraga H; Department of Orthopaedic Surgery, Hokkaido Cancer Center, Sapporo, Japan.
  • Hiraoka K; Department of Orthopaedic Surgery, Kurume University, Kurume, Japan.
  • Watanuki M; Department of Orthopaedic Surgery, Tohoku University Hospital, Sendai, Japan.
  • Yonemoto T; Department of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan.
  • Abe S; Department of Orthopaedic Surgery, Teikyo University, Tokyo, Japan.
  • Katagiri H; Department of Orthopaedic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Nishida Y; Department of Orthopaedic Surgery, Nagoya University, Nagoya, Japan.
  • Nagano A; Department of Orthopaedic Surgery, Gifu University, Gifu, Japan.
  • Suehara Y; Department of Orthopaedic Surgery, Juntendo University, Tokyo, Japan.
  • Kawashima H; Department of Orthopaedic Surgery, Niigata University, Niigata, Japan.
  • Kawano M; Department of Orthopaedic Surgery, Oita University, Oita, Japan.
  • Morii T; Department of Orthopaedic Surgery, Kyorin University, Tokyo, Japan.
  • Hatano H; Department of Orthopaedic Surgery, Niigata Cancer Center Hospital, Niigata, Japan.
  • Toguchida J; Department of Orthopaedic Surgery, Kyoto University, Kyoto, Japan.
  • Okuma T; Department of Musculoskeletal Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Takeyama M; Department of Orthopaedic Surgery, Yokohama City University, Kanagawa, Japan.
  • Takenaka S; Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan.
  • Akisue T; Department of Orthopaedic Surgery, Kobe University, Kobe, Japan.
  • Furuta T; Department of Orthopaedic Surgery, Hiroshima University, Hiroshima, Japan.
  • Emori M; Department of Orthopaedic Surgery, Sapporo Medical University, Sapporo, Japan.
  • Hiruma T; Department of Musculoskeletal Tumor Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  • Outani H; Department of Orthopaedic Surgery, Osaka University, Osaka, Japan.
  • Yamamoto T; Department of Orthopaedic Surgery, Kagawa University, Kagawa, Japan.
  • Kataoka T; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Fukuda H; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Ozaki T; Department of Orthopaedic Surgery, Okayama University, Okayama, Japan.
  • Iwamoto Y; Kyushu Rosai Hospital, Kitakyushu, Japan.
Br J Cancer ; 127(8): 1487-1496, 2022 11.
Article em En | MEDLINE | ID: mdl-35871234

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Neutropenia Febril Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Neutropenia Febril Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão